Role of tumor necrosis factor alpha (TNF-alpha) and interleukin-10 in the pathogenesis of severe murine monocytotropic ehrlichiosis: increased resistance of TNF receptor p55- and p75-deficient mice to fatal ehrlichial infection
- PMID: 16495559
- PMCID: PMC1418656
- DOI: 10.1128/IAI.74.3.1846-1856.2006
Role of tumor necrosis factor alpha (TNF-alpha) and interleukin-10 in the pathogenesis of severe murine monocytotropic ehrlichiosis: increased resistance of TNF receptor p55- and p75-deficient mice to fatal ehrlichial infection
Abstract
Intraperitoneal (i.p.) infection with a high dose of a highly virulent Ehrlichia strain (IOE) results in a toxic shock-like syndrome characterized by severe liver injury and systemic overproduction of tumor necrosis factor alpha (TNF-alpha) by CD8+ T cells. We examined the role of TNF-alpha and TNF receptors in high-dose-IOE-induced shock/liver injury. TNF receptor (TNFR) I/II-/- mice lacking both the p55 and p75 receptors for this cytokine were more resistant to IOE-induced liver injury than their wild-type background controls. TNFR I/II-/- mice survived longer, dying between 15 and 18 days, with evidence of mild liver necrosis/apoptosis. In contrast, wild-type mice were not rescued from the lethal effect of IOE by TNF-alpha neutralization. TNF-alpha-depleted mice developed severe liver injury and succumbed to disease between days 9 and 11 postinfection, similar to sham-treated, infected wild-type mice. Although IFN-gamma production in the spleens of IOE-infected TNFR I/II-/- and TNF-alpha-depleted mice was higher than that detected in wild-type controls, these mice had higher bacterial burdens than infected controls. Following high-dose IOE challenge, TNFR I/II-/- and TNF-alpha-depleted mice have an early increase in IL-10 levels in sera and spleens, which was produced mainly by adherent spleen cells. In contrast, a late burst of interleukin-10 (IL-10) was observed in control mice. Nonadherent spleen cells were the major source of IL-10 in IOE-infected wild-type mice. We conclude that TNFR I/II and TNF-alpha participate in Ehrlichia-induced shock and host defense by regulating liver injury and controlling ehrlichial burden. Our data suggest that fatal ehrlichiosis could be a multistep process, where TNF-alpha is not solely responsible for mortality.
Figures









Similar articles
-
Overproduction of TNF-alpha by CD8+ type 1 cells and down-regulation of IFN-gamma production by CD4+ Th1 cells contribute to toxic shock-like syndrome in an animal model of fatal monocytotropic ehrlichiosis.J Immunol. 2004 Feb 1;172(3):1786-800. doi: 10.4049/jimmunol.172.3.1786. J Immunol. 2004. PMID: 14734762
-
An intradermal environment promotes a protective type-1 response against lethal systemic monocytotropic ehrlichial infection.Infect Immun. 2006 Aug;74(8):4856-64. doi: 10.1128/IAI.00246-06. Infect Immun. 2006. PMID: 16861674 Free PMC article.
-
Relative importance of T-cell subsets in monocytotropic ehrlichiosis: a novel effector mechanism involved in Ehrlichia-induced immunopathology in murine ehrlichiosis.Infect Immun. 2007 Sep;75(9):4608-20. doi: 10.1128/IAI.00198-07. Epub 2007 Jun 11. Infect Immun. 2007. PMID: 17562770 Free PMC article.
-
Mechanisms of TNF-alpha-induced insulin resistance.Exp Clin Endocrinol Diabetes. 1999;107(2):119-25. doi: 10.1055/s-0029-1212086. Exp Clin Endocrinol Diabetes. 1999. PMID: 10320052 Review.
-
Ehrlichia under our noses and no one notices.Arch Virol Suppl. 2005;(19):147-56. doi: 10.1007/3-211-29981-5_12. Arch Virol Suppl. 2005. PMID: 16358425 Review.
Cited by
-
Natural killer cells promote tissue injury and systemic inflammatory responses during fatal Ehrlichia-induced toxic shock-like syndrome.Am J Pathol. 2010 Aug;177(2):766-76. doi: 10.2353/ajpath.2010.091110. Epub 2010 Jul 8. Am J Pathol. 2010. PMID: 20616341 Free PMC article.
-
Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.Clin Microbiol Rev. 2020 Jun 10;33(3):e00035-19. doi: 10.1128/CMR.00035-19. Print 2020 Jun 17. Clin Microbiol Rev. 2020. PMID: 32522746 Free PMC article. Review.
-
Progress and obstacles in vaccine development for the ehrlichioses.Expert Rev Vaccines. 2010 Sep;9(9):1071-82. doi: 10.1586/erv.10.93. Expert Rev Vaccines. 2010. PMID: 20822349 Free PMC article. Review.
-
Emerging Roles of Autophagy and Inflammasome in Ehrlichiosis.Front Immunol. 2019 May 8;10:1011. doi: 10.3389/fimmu.2019.01011. eCollection 2019. Front Immunol. 2019. PMID: 31134081 Free PMC article. Review.
-
IgM production by bone marrow plasmablasts contributes to long-term protection against intracellular bacterial infection.J Immunol. 2011 Jan 15;186(2):1011-21. doi: 10.4049/jimmunol.1002836. Epub 2010 Dec 8. J Immunol. 2011. PMID: 21148037 Free PMC article.
References
-
- Bean, A. G., D. R. Roach, H. Briscoe, M. P. France, H. Korner, J. D. Sedgwick, and W. J. Britton. 1999. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J. Immunol. 162:3504-3511. - PubMed
-
- Bitsaktsis, C., J. Huntington, and G. Winslow. 2004. Production of IFN-gamma by CD4 T cells is essential for resolving ehrlichia infection. J. Immunol. 172:6894-6901. - PubMed
-
- Bogdan, C., M. Rollinghoff, and A. Diefenbach. 2002. The role of nitric oxide in innate immunity. Immunol. Rev. 173:17-26. - PubMed
-
- Chan, K. F., M. R. Siegel, and J. M. Lenardo. 2000. Signaling by the TNF receptor superfamily and T cell homeostasis. Immunity 13:419-422. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials